Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alessandro Rizzo, Angela Dalia Ricci, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Giorgio Frega & Giovanni Brandi. (2021) Experimental HER2- targeted therapies for biliary tract cancer. Expert Opinion on Investigational Drugs 30:4, pages 389-399.
Read now
Read now
Articles from other publishers (24)
Jialing Huang, Guoli Chen & Hongjie Li. (2023) An Update on the Role of Immunohistochemistry in the Evaluation of Pancreatic/Liver/Gastrointestinal Luminal Tract Disorders. Archives of Pathology & Laboratory Medicine 147:12, pages 1374-1382.
Crossref
Crossref
Ingrid M. Montes‐Rodríguez, Hilmaris Centeno‐Girona, Camila Rivera‐Lynch, Noridza Rivera & Marcia Cruz‐Correa. (2023) Molecular profiling of colorectal cancer in a genetically admixed Hispanic population. Cancer Medicine 12:10, pages 11686-11702.
Crossref
Crossref
Íris Neto, João Rocha, Maria Manuela Gaspar & Catarina P. Reis. (2023) Experimental Murine Models for Colorectal Cancer Research. Cancers 15:9, pages 2570.
Crossref
Crossref
Edwin de Jong & Armagan Kocer. (2023) Current Methods for Identifying Plasma Membrane Proteins as Cancer Biomarkers. Membranes 13:4, pages 409.
Crossref
Crossref
S.V. Vtorushin, N.V. Krakhmal, L.E. Zavalishina, O.A. Kuznetsova, L.V. Moskvina & G.A. Frank. (2023) Assessment of HER2 status of carcinomas of various localizations. Arkhiv patologii 85:6, pages 31.
Crossref
Crossref
Li Cao, Guanglong Dong & Huan Li. (2022) CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer. BMC Gastroenterology 22:1.
Crossref
Crossref
Bouchra Ghazi, Adil El Ghanmi, Sarah Kandoussi, Amina Ghouzlani & Abdallah Badou. (2022) CAR T-cells for colorectal cancer immunotherapy: Ready to go?. Frontiers in Immunology 13.
Crossref
Crossref
Nannan Wang, Yuepeng Cao, Chengshuai Si, Peng Shao, Guoqing Su, Ke Wang, Jun Bao & Liu Yang. (2022) Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies. Cancers 14:20, pages 5160.
Crossref
Crossref
Xiaoling Qin, Fengjiao Wu, Chang Chen & Qi Li. (2022) Recent advances in CAR-T cells therapy for colorectal cancer. Frontiers in Immunology 13.
Crossref
Crossref
Guillermo Valenzuela, Mauricio Burotto, Katherine Marcelain & Jaime González-Montero. (2022) Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. World Journal of Gastrointestinal Oncology 14:9, pages 1654-1664.
Crossref
Crossref
Javier Torres-Jiménez, Jorge Esteban-Villarrubia & Reyes Ferreiro-Monteagudo. (2022) Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene. Cancers 14:15, pages 3718.
Crossref
Crossref
Ali Abdulnabi Suwaidan, David K. Lau & Ian Chau. (2022) HER2 targeted therapy in colorectal cancer: New horizons. Cancer Treatment Reviews 105, pages 102363.
Crossref
Crossref
Jie Xu, Qingtao Meng, Hao Sun, Xinwei Zhang, Jun Yun, Bin Li, Shenshen Wu, Xiaobo Li, Hongbao Yang, Haitao Zhu, Michael Aschner, Michela Relucenti, Giuseppe Familiari & Rui Chen. (2021) HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer. Cell Death & Disease 12:12.
Crossref
Crossref
Miao Jiang, Shuiling Jin, Jinming Han, Tong Li, Jianxiang Shi, Qian Zhong, Wen Li, Wenxue Tang, Qinqin Huang & Hong Zong. (2021) Detection and clinical significance of circulating tumor cells in colorectal cancer. Biomarker Research 9:1.
Crossref
Crossref
May Cho, Ryan Beechinor, Sepideh Gholami & Axel Grothey. (2021) Precision Medicine for the Treatment of Colorectal Cancer: the Evolution and Status of Molecular Profiling and Biomarkers. Current Colorectal Cancer Reports 17:4, pages 55-68.
Crossref
Crossref
Francesca Imbastari, Mathias Dahlmann, Anje Sporbert, Camilla Ciolli Mattioli, Tommaso Mari, Florian Scholz, Lena Timm, Shailey Twamley, Rebekka Migotti, Wolfgang Walther, Gunnar Dittmar, Armin Rehm & Ulrike Stein. (2021) MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer. Cellular and Molecular Life Sciences 78:7, pages 3525-3542.
Crossref
Crossref
Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocío García-Carbonero, Jesús García-Foncillas, Pedro Pérez-Segura, Ramón Salazar, Ruth Vera & Pilar García-Alfonso. (2021) Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica. Revista Española de Patología 54:1, pages 41-54.
Crossref
Crossref
Evelina Miele, Luana Abballe, Gian Paolo Spinelli, Zein Mersini Besharat, Giuseppina Catanzaro, Martina Chiacchiarini, Alessandra Vacca, Agnese Po, Carlo Capalbo & Elisabetta Ferretti. (2020) BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors. BMC Cancer 20:1.
Crossref
Crossref
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas & S. Navarro. (2020) Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical and Translational Oncology 22:11, pages 1976-1991.
Crossref
Crossref
Akram Tayanloo-Beik, Masoumeh Sarvari, Moloud Payab, Kambiz Gilany, Sepideh Alavi-Moghadam, Mahdi Gholami, Parisa Goodarzi, Bagher Larijani & Babak Arjmand. (2020) OMICS insights into cancer histology; Metabolomics and proteomics approach. Clinical Biochemistry 84, pages 13-20.
Crossref
Crossref
Qing-Hai Li, Ying-Zhao Wang, Jian Tu, Chu-Wei Liu, Yu-Jie Yuan, Run Lin, Wei-Ling He, Shi-Rong Cai, Yu-Long He & Jin-Ning Ye. (2020) Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance. Gastroenterology Report 8:3, pages 179-191.
Crossref
Crossref
Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran & Xiaoming Xing. (2020)
HER2
and
BRAF
mutation in colorectal cancer patients: a retrospective study in Eastern China
. PeerJ 8, pages e8602.
Crossref
Crossref
Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, Caterina Chiapparino, Antonio Rosi, Giuseppe Giannini, Maurizio Taddei, Elena Cini, Valentina Faltoni, Elena Petricci, Gianfranco Battistuzzi, Laura Salvini, Valeria Carollo & Rita De Santis. (2020) ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1. Frontiers in Oncology 9.
Crossref
Crossref
Justine Fritz, Olivier Lefebvre, Aurore Fernandez, Jordane Schmidt & Dominique Bagnard. (2020) Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression. Cancers 12:1, pages 149.
Crossref
Crossref